• Info

Nasus Pharma Ltd SEC EDGAR Filings (CIK 0002029039)

SEC EDGAR filings, ownership reports, and insider transactions for Nasus Pharma Ltd.

Symbol
NSRX on NYSE
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
29 Harakevet St, Tel Aviv Yafo, Israel, 6618003
State of incorporation
Israel
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Nasus Pharma Ltd has filed 52 SEC EDGAR filings since 30 Aug 2024

Latest Filings

Recent SEC filings for Nasus Pharma Ltd including 6-K, SCHEDULE 13G, 424B4 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
6-K Open 6-K document View SEC filing for 6-K 6-K 29 Jan 2026 29 Jan 2026 001-42796
6-K Open 6-K document View SEC filing for 6-K 6-K 20 Jan 2026 20 Jan 2026 001-42796
6-K Open 6-K document | Open XBRL data View SEC filing for 6-K 6-K 29 Dec 2025 30 Jun 2025 001-42796
6-K Open 6-K document View SEC filing for 6-K 6-K 22 Dec 2025 22 Dec 2025 001-42796
6-K Open 6-K document View SEC filing for 6-K 6-K 20 Nov 2025 20 Nov 2025 001-42796
6-K Open 6-K document View SEC filing for 6-K 6-K 18 Nov 2025 18 Nov 2025 001-42796
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 13 Nov 2025 005-95201
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 12 Nov 2025 005-95201
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 10 Nov 2025 005-95201
6-K Open 6-K document View SEC filing for 6-K 6-K 03 Nov 2025 03 Nov 2025 001-42796
6-K Open 6-K document View SEC filing for 6-K 6-K 08 Oct 2025 08 Oct 2025 001-42796
6-K Open 6-K document View SEC filing for 6-K 6-K 30 Sep 2025 30 Sep 2025 001-42796
6-K Open 6-K document View SEC filing for 6-K 6-K 05 Sep 2025 05 Sep 2025 001-42796
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 20 Aug 2025 005-95201
6-K Open 6-K document View SEC filing for 6-K 6-K 14 Aug 2025 14 Aug 2025 001-42796
424B4 Open 424B4 document View SEC filing for 424B4 424B4 14 Aug 2025 333-288582
EFFECT Open EFFECT document View SEC filing for EFFECT 12 Aug 2025 333-288582
CERT Open CERT document View SEC filing for CERT NYSE AMERICAN CERTIFICATION 12 Aug 2025 001-42796
CORRESP Open CORRESP document View SEC filing for CORRESP 08 Aug 2025
CORRESP Open CORRESP document View SEC filing for CORRESP 08 Aug 2025
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 08 Aug 2025 001-42796
CORRESP Open CORRESP document View SEC filing for CORRESP 07 Aug 2025
F-1/A Open F-1/A document View SEC filing for F-1/A F-1/A 07 Aug 2025 333-288582
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 06 Aug 2025 377-07416
FWP Open FWP document View SEC filing for FWP FWP 30 Jul 2025 333-288582
FWP Open FWP document View SEC filing for FWP FWP 28 Jul 2025 333-288582
CORRESP Open CORRESP document View SEC filing for CORRESP 28 Jul 2025
F-1/A Open F-1/A document | Open XBRL data View SEC filing for F-1/A F-1/A 28 Jul 2025 333-288582
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 16 Jul 2025 377-07416
F-1 Open F-1 document | Open XBRL data View SEC filing for F-1 F-1 09 Jul 2025 333-288582
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 21 May 2025
DRS/A Open DRS/A document View SEC filing for DRS/A 21 May 2025 377-07416
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 20 May 2025 377-07416
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 12 May 2025
DRS/A Open DRS/A document View SEC filing for DRS/A 12 May 2025 377-07416
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 07 May 2025 377-07416
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 29 Apr 2025
DRS/A Open DRS/A document View SEC filing for DRS/A 29 Apr 2025 377-07416
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 22 Apr 2025 377-07416
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 16 Apr 2025
DRS/A Open DRS/A document View SEC filing for DRS/A 16 Apr 2025 377-07416
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 28 Mar 2025 377-07416
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 21 Mar 2025
DRS/A Open DRS/A document View SEC filing for DRS/A 21 Mar 2025 377-07416
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 18 Feb 2025 377-07416
DRS/A Open DRS/A document View SEC filing for DRS/A 06 Feb 2025 377-07416
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 05 Feb 2025
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 28 Jan 2025 377-07416
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 31 Dec 2024
DRS/A Open DRS/A document View SEC filing for DRS/A 31 Dec 2024 377-07416
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 27 Sep 2024 377-07416
DRS Open DRS document View SEC filing for DRS 30 Aug 2024 377-07416

About this filer

Nasus Pharma Ltd files with the SEC under CIK 0002029039. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages